214 related articles for article (PubMed ID: 37702845)
1. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS).
Parillo M; Mallio CA; Van der Molen AJ; Rovira À; Dekkers IA; Karst U; Stroomberg G; Clement O; Gianolio E; Nederveen AJ; Radbruch A; Quattrocchi CC;
MAGMA; 2024 Feb; 37(1):15-25. PubMed ID: 37702845
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
[TBL] [Abstract][Full Text] [Related]
4. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field.
Watanabe M; Taguchi S; Machida H; Tambo M; Takeshita Y; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Fukuhara H; Yokoyama K
Eur Radiol; 2022 Nov; 32(11):7513-7521. PubMed ID: 35554648
[TBL] [Abstract][Full Text] [Related]
5. Simplified Prostate Imaging Reporting and Data System for Biparametric Prostate MRI: A Proposal.
Scialpi M; Aisa MC; D'Andrea A; Martorana E
AJR Am J Roentgenol; 2018 Aug; 211(2):379-382. PubMed ID: 29894218
[TBL] [Abstract][Full Text] [Related]
6. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Evaluation of late Gadolinium Enhancement to the Differential Diagnosis of Prostate Cancer and Prostatitis in mpMRI.
Aydin H; Topsakal K; Ayyildiz VA; Aydin H; Karaibrahimoglu A
J Coll Physicians Surg Pak; 2023 Jan; 33(1):20-26. PubMed ID: 36597230
[TBL] [Abstract][Full Text] [Related]
8. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
[TBL] [Abstract][Full Text] [Related]
9. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
10. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
Panebianco V; Narumi Y; Altun E; Bochner BH; Efstathiou JA; Hafeez S; Huddart R; Kennish S; Lerner S; Montironi R; Muglia VF; Salomon G; Thomas S; Vargas HA; Witjes JA; Takeuchi M; Barentsz J; Catto JWF
Eur Urol; 2018 Sep; 74(3):294-306. PubMed ID: 29755006
[TBL] [Abstract][Full Text] [Related]
11. Brain MRI and clinical exam findings in women with multiple gadolinium-based contrast agent (GBCA) exposures due to screening breast MRIs.
Myers KS; Yousem DM; Mills KA; Gad K; Niri SG; Bienko N; Munro CA
Clin Imaging; 2022 Dec; 92():57-62. PubMed ID: 36202017
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium contrast agent selection and optimal use for body MR imaging.
Guglielmo FF; Mitchell DG; Gupta S
Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
[TBL] [Abstract][Full Text] [Related]
13. Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals.
Hu YS; Wu CA; Lin DC; Lin PW; Lee HJ; Lin LY; Lin CJ
Cancer Imaging; 2024 Feb; 24(1):22. PubMed ID: 38326850
[TBL] [Abstract][Full Text] [Related]
14. Estimation of Gadolinium-based Contrast Agent Concentration Using Quantitative Synthetic MRI and Its Application to Brain Metastases: A Feasibility Study.
Fujita S; Nakazawa M; Hagiwara A; Ueda R; Horita M; Maekawa T; Irie R; Andica C; Kunishima Kumamaru K; Hori M; Aoki S
Magn Reson Med Sci; 2019 Oct; 18(4):260-264. PubMed ID: 30787250
[TBL] [Abstract][Full Text] [Related]
15. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
[TBL] [Abstract][Full Text] [Related]
16. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
17. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
Pricolo P; Ancona E; Summers P; Abreu-Gomez J; Alessi S; Jereczek-Fossa BA; De Cobelli O; Nolè F; Renne G; Bellomi M; Padhani AR; Petralia G
Cancer Imaging; 2020 Oct; 20(1):77. PubMed ID: 33109268
[TBL] [Abstract][Full Text] [Related]
18. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
Ichikawa S; Omiya Y; Onishi H; Motosugi U
J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-based contrast agent attenuation does not impact PET quantification in simultaneous dynamic contrast enhanced breast PET/MR.
Allen TJ; Henze Bancroft LC; Kumar M; Bradshaw TJ; Strigel RM; McMillan AB; Fowler AM
Med Phys; 2022 Aug; 49(8):5206-5215. PubMed ID: 35621727
[TBL] [Abstract][Full Text] [Related]
20. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
